Zymeworks Inc.
ZYME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,294 | $945 | $895 | $1,110 |
| - Cash | $64,834 | $98 | $76 | $66 |
| + Debt | $18,904 | $19 | $18 | $19 |
| Enterprise Value | -$44,636 | $866 | $838 | $1,063 |
| Revenue | $28 | $49 | $27 | $31 |
| % Growth | -43.3% | 79.7% | -12.6% | – |
| Gross Profit | $28 | $49 | $27 | $31 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$16 | $3 | -$22 | -$19 |
| % Margin | -56.8% | 5.3% | -82.3% | -59.8% |
| Net Income | -$20 | $2 | -$23 | -$24 |
| % Margin | -71% | 4.8% | -83.5% | -75.8% |
| EPS Diluted | -0.26 | 0.03 | -0.3 | -0.31 |
| % Growth | -966.7% | 110% | 3.2% | – |
| Operating Cash Flow | -$31 | $12 | -$3 | -$42 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$32 | $11 | -$4 | -$42 |